Immune Responses in Patients Treated With Raltegravir (RAG-1/2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00785967|
Recruitment Status : Withdrawn (Unexpected and severe difficulties in recruitment.)
First Posted : November 5, 2008
Last Update Posted : April 14, 2015
McGill University Health Center
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Chris Tsoukas, McGill University Health Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||August 2011|
|Actual Study Completion Date :||August 2011|